[ RECIPIENT ENTITY RECORD ]

Horizon Therapeutics

VERIFIED NODE ID: 002032 · horizon-therapeutics
R TARGET NODE — CAPITAL RECIPIENT
Horizon Therapeutics
Company Ireland
Recipient Type
Company
Primary Jurisdiction
Ireland
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Horizon Therapeutics
Entity Type Company
Jurisdiction Ireland
Recipient Intelligence Summary

Horizon Therapeutics is a global biotechnology company focused on the discovery and development of medicines that address critical unmet needs for people with rare diseases. Based in Dublin, the company is a leader in inflammation and orphan drug research. It was a primary destination for institutional healthcare capital during its strategic takeover.

Capital Influx Log (Transactions)
Date Type Amount
23 May 2026 EQUITY $27.8B